1427064-46-7

Basic information

• Product Name: 5-(tetrahydropyran-4-yl)-6-(2,2,2-trifluoroethoxy)nicotinic acid N′-methyl-N′-phenylhydrazide
• Synonyms: 5-(tetrahydropyran-4-yl)-6-(2,2,2-trifluoroethoxy)nicotinic acid N′-methyl-N′-phenylhydrazide
• CAS NO: 1427064-46-7
• Molecular Weight: 409.408
• Mol File: 1427064-46-7.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: 5-(tetrahydropyran-4-yl)-6-(2,2,2-trifluoroethoxy)nicotinic acid N′-methyl-N′-phenylhydrazide(CAS DataBase Reference)
• NIST Chemistry Reference: 5-(tetrahydropyran-4-yl)-6-(2,2,2-trifluoroethoxy)nicotinic acid N′-methyl-N′-phenylhydrazide(1427064-46-7)
• EPA Substance Registry System: 5-(tetrahydropyran-4-yl)-6-(2,2,2-trifluoroethoxy)nicotinic acid N′-methyl-N′-phenylhydrazide(1427064-46-7)

Safety Data

• Hazardous Substances Data: 1427064-46-7(Hazardous Substances Data)

Upstream product

• 1211589-51-3 5-bromo-6-(2,2,2-trifluoroethoxy)-3-pyridinecarboxylic acid methyl ester 
• 1427064-92-3 5-(tetrahydropyran-4-yl)-6-(2,2,2-trifluoroethoxy)nicotinic acid 
• 618-40-6 1-Methyl-1-phenylhydrazine 
• 1427064-91-2 5-(tetrahydropyran-4-yl)-6-(2,2,2-trifluoroethoxy)nicotinic acid methyl ester 
• 25637-18-7 4-iodotetrahydropyran 

Relevant articles and documents

3-PYRIDINE CARBOXYLIC ACID HYDRAZIDES

The present invention relates to compounds of formula I, wherein R1 to R5 are defined in the description and claims, and to pharmaceutically acceptable salts thereof. The present invention relates also to the manufacture of said compounds, pharmaceutical compositions containing them and methods for the treatment and/or prophylaxis of diseases which can be treated with HDL-cholesterol raising agents, such as dyslipidemia, atherosclerosis and cardiovascular diseases.